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The clinical trials demonstrated that the CHG dressing reduced CLABSI and/
or CRBSI by approximately 60%. Standard measures of health economic
benefit compared favorably to published results for a range of costs associ-
ated with CRBSI treatment.
Conclusion: 3M  Tegaderm  chlorhexidine gluconate securement dressing
has been shown to reduce clinical sepsis in a cost effective manner with bio-
film reducing properties.
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THE RISK FACTORS FOR MORTALITY IN LIVER TRANSPLANT RECIPIENTS
WITH BLOODSTREAM INFECTIONS
Ching Ching Chang 1, Yin Yin Chen 1,2, Fu Der Wang 1,2,3. 1Infection Control
Committee, Taipei Veterans General Hospital; 2National Yang-Ming
University; 3Medical Department, Taipei Veterans General Hospital
Purpose: Bloodstream infections(BSIs) are common among liver transplant
recipients. Mortality rates in subjects with BSIs have been reported to range
from 10% to50%. The purpose of our study was to determine the risk factors
for Mortality in Liver Transplant Recipients With Bloodstream Infections.
Methods: We retrospectively reviewed the data from 132 patients who un-
derwent liver transplant recipients between Between January 2008 and
2013. We performed liver transplantations in 132 subjects who experienced
35 episodes of BSIs. We assessed risk factors for mortality among 26 of them
using univariate and multivariate logistic regression analysis.
Results: The 26 recipients (19.7%) who developed BSI showed amean age of 55
(55 10). There were 9 deaths among these recipients (34.6%).The univariate
analysis identified the following variables as risk factors for BSI-related mor-
tality:LDLT(P Z 032), in the ICU(P Z 004), higher APACHE II score(P Z
012),septic shock(P Z 004)，Continuous venovenous hemofiltration (P Z
033),lower platelet count (P Z 033), prolonged INR (P Z 005) ,mechanical
ventilation (P Z 001) ,central vein catheter(P Z 001) , urethral catheter(P
Z 001).Multivariate logistic regression showed no statistically significant..
Conclusions: The risk factors significantly associated with increased mortal-
ity in liver transplant recipients with BSIs are higher APACHE II score, in the
ICU,septic shock, lower platelet count, prolonged INR,CVVH,invasive cath-
eter were associated with high mortality.
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CLINICAL AND MICROBIAL CHARACTERISTICS OF 679 EPISODES OF
BLOODSTREAM INFECTIONS
Y. Yao, B. Hu, C. Zhou, X. Gao. Zhongshan Hospital, Fudan University,
Shanghai, China
Purpose: The incidence of bloodstream infection (BSI) in China is increasing.
The purpose of this research is to study the clinical and microbial character-
istics of BSIs in order to provide guidance for future clinical practices.
Methods: We retrospectively collected all diagnosed cases of bloodstream
infections between Jan. 2012 and Dec. 2013 in Zhongshan Hospital, a
1700-bed teaching hospital of China. Demographic, clinical, laboratory and
microbial information, and outcome were documented and analyzed.
Results: A total of 679 episodes of BSIs were detected in 585 patients (58.3 
15.4y, 406 male). The departments with the most cases were cardiac surgery
(21.8%), general surgery (13.8%) and liver surgery (9.4%). 32.4% of the episodes
happened in ICU. Leukocytopenia were seen in 7.2% of the cases, hypoalbumi-
nemia 34.3%, and CVC in place 44.2%. Among 613 episodes of the monomicro-
bial BSIs, Gram-positive bacteria caused 34.3%, Gram-negative organisms
57.6% and fungi 8.2%. The most common pathogens were Escherichia Coli
(20.7%), Klebsiella pneumoniae (10.8%), Coagulase negative staphylococci
(9.0%), Staphylococcus aureus (9.0%), Enterococcus spp. (7.8%), Candida spp
(7.7%), and Streptococcus spp (7.7%). CoNS (17.5%) and Candida spp (15.1%)
weremost commonly isolated in cardiac surgerywards,whereas E. coli caused
the most episodes in general surgery (16.3%) and hepatic surgery (34.4%).
Overall 30-day mortality rate was 20.2%. It was 10.9% in common wards and
39.6% in ICU; 53.7% for organ transplant recipients; 18.8% and 33.3% for mono-
microbial and polymicrobial BSIs respectively. Acinetobacter Baumanni
(42.4%), Candida spp (31.9%), S aureaus (25.5%), Enterococcus spp (22.9%),
CoNS (21.8%) have the highest 30-day mortality rate.
Conclusions: BSI incidences were highest in surgical departments. E coli,
Klebsiella pneumoniae, CoNS, and S aureus were the most common
pathogens. Microbial distributions differ greatly among clinical settings.
ICU stay, organ transplantation, polymicrobial BSI, multi-drug resistant bac-
teria infection, and candida infection had the highest mortality rate.
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WHAT DO WE LEARN FROM ANTIMICROBIAL PHOTODYNAMIC THERAPY?
Tak-Wah Wong 1,2, Wen-Chien Ko 1,3, Yin-Ching Chuang 4, Chun-Keung Yu 5,
I-Hsiu Huang 1,5. 1Antimicrobial Photodynamic Therapy Team; 2Departments
of Dermatology, Biochemistry and Molecular Biology; 3Division of Infectious
Diseases, Department of Medicine, National Cheng Kung University Medical
College and Hospital; 4Department of Internal Medicine, Chi Mei Medical
Center, Liou Ying Campus; 5Department of Microbiology and Immunology,
National Cheng Kung University Medical College, Tainan, Taiwan
Purpose: Infectious diseases are increasingly serious threats to global public
health that requires action. Photodynamic therapy (PDT) eradicates micro-
organisms by generating reactive cytotoxic oxygen products after photoacti-
vating a particular photosensitizer with certain wavelength of light in cells.
The damages are non-selective. Therefore, PDT-resistant strains are less
likely to induce. We described our 10 years studies and experiences in anti-
microbial PDT in southern Taiwan.
Methods: Antimicrobial PDT on viral and bacterial infections was examined
in vitro and in vivo. Enteroviruses, Vibrio vulnificus and oxacillin-resistant
Staphylococcus aureus (ORSA) were used as models of viral and bacterial in-
fections, respectively.
Results: Antimicrobial PDT effectively inhibits transmission of enteroviruses
and kills bacteria in a relative low dose, both in vitro and in mice. Impor-
tantly, PDT enhanced wound healing in chronic infected ulcers in patients,
probably worked through direct bactericidal effects and altering local micro-
environment. Interestingly, we found ORSA become sensitive to oxacillin af-
ter one PDT treatment.
Conclusions: Antimicrobial PDT may have potential to become a new or an
adjuvant therapy against microbial infections.
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CAUSES OF FATALITY ASSOCIATED WITH PROSPECTIVE ANTIMICROBIAL
AUDIT WITH FEEDBACK
Shu-Hsing Cheng 1,*, Chien-Yu Cheng 1, Chien-Yu Lee 2. 1Department of
Infectious Diseases; 2Department of Pediatrics, Taoyuan General Hospital,
Ministry of Health and Welfare, Taoyuan, Taiwan
Purpose: Previous researches had not powered adequately to demonstrate
prospective antimicrobial audit with feedback have impacts on the patient’s
outcomes. In this study, the causes of fatality associated with prospective
antimicrobial audit with feedback were analyzed.
Methods: Between June and September 2014, the applications for 25 target
parenteral formulae which were rejected by infectious diseases specialists
(IDs) were followed up until patients were either discharged or died.
Results: There were 292 cases included. There were 193 (66%) male pa-
tients, and their mean ages (standard deviation) were 65.5(19.3) years.
Among them, 38 (13%) had history of diabetes mellitus, 12.3% had end stage
renal diseases, and 11.6% had malignancies. Common reasons for rejection
included 37% of dosage adjustments, 28.8% of no bacterial evidences,
18.8% of modifications by antimicrobial susceptibility, and 7.2% of target
pathogens not being covered.
Table Factors related to case fatalities using multiple logistic regres-
sion analyses adjusted by sex
Characteristic factors Odds ratio 95% Confidence
interval
P value
Ages more than 75 years old 2.58 1.32-5.50 0.005
Urinary tract infection 0.26 0.09-0.70 0.013
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Conclusions: On account of old age and some of them had given up aggres-
sive treatments, antimicrobial adjustment by IDs’ recommendation showed
only marginal effects against fatality. Under such circumstances, it should
be more prudent to prescribe antibiotics.
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THE ANTIMICROBIAL STEWARDSHIP PROGRAMMES REDUCE MULTIDRUG
RESISTANT ACINETOBACTER BAUMANNII INFECTION IN THE INTENSIVE
CARE UNIT (ICU) OF SILOAM HOSPITAL, TANGERANG, INDONESIA
Cucunawangsih 1,2, Ratna Sari Wijaya 1, Audric Albertus 1,
Primartanto Wibowo 3. 1Faculty of Medicine, PelitaHarapan University,
Tangerang; 2Department of Microbiology, Siloam Hospital, Tangerang;
3Intensive Care Unit, Siloam Hospital, Tangerang
Purpose: Multidrug resistant Acinetobacter baumannii is one of the most
common cause of hospital acquired infection (HAIs) in intensive care units
(ICUs) worldwide and commonly associated with increasing mortality and
length of stay. To address with the increasing of multi-drug resistant A.bau-
mannii infection, antimicrobial stewardship programmes are promoted
worldwide to encourage judicious antimicrobial use and prevent the emer-
gence of resistance. The aim of this study is to determine the impact of
the antimicrobial stewardship programmes in preventing the development
of A. baumannii antimicrobial resistance.
Methods: During the period from June 2012 till June 2013, A. baumanii iso-
lates data from sputum, wound, blood, urine, and cerebro-spinal fluid were
collected and used as a baseline data. The identification of A.baumannii and
resistant pattern was performed by using VITEX 2 Compact according to
Clinical Laboratory and Standards Institute (CLSI). Socialization and imple-
mentation of the antimicrobial stewardship programmes including; (1)
determining the empirical antimicrobial drug use in the ICU, (2) using the
antibiotic prescription chart to ensure antibiotic prescription based on
microbiological culture and sensitivity.
Results: From the baseline data, A baumannii found in 16 isolates and were
multidrug resistant. The majority of the isolates sensitive to colistin (100%)
and cefoporazone/sulbactame (77%). After the implementation of antimi-
crobial stewardship programmes, the incidence of A.baumannii finding
was decreasing into 3 isolates and showed the increasing sensitivity to cefo-
porazone/sulbactame (89%) that use as empirical therapy for gram negative
bacteria infection in the ICU. The sensitivity to the other antimicrobial; car-
bapenem, imipenem, meropenem, aminoglycoside were also increasing.
Conclusions: Our result of the antimicrobial stewardship programmes
showed the improvement A.baumannii sensitivity to the first-line antimicro-
bials. To have the antimicrobial stewardship programmes helped us to
decrease the rate of bacterial resistance within our hospital.
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EVALUATION OF LEVOFLOXACIN UTILIZATION RATIONALITY BY
COMPUTERIZED PHYSICIAN ORDER ENTRY SYSTEM
Ya-Ling Ke 1, Hui-Hsia Hsieh 2, Tien-Yuan Wu 2, Yung-Ta Lin 2, Chi-
Hua Chen 3. 1Pharmaceutic Division, Department of Pharmacy, Taichung Tzu
Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan;
2Clinical Pharmacy Division, Department of Pharmacy, Taichung Tzu Chi
Hospital, Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan;
3Department of Pharmacy, Taichung Tzu Chi Hospital, Buddhist Tzu Chi
Medical Foundation, Taichung, Taiwan
Purpose: Levofloxacin belongs to the third-generation Fluoroquinolones
(FQs). It is not only the broad-spectrum antibiotic for G (＋) and G ()
(Escherichia coli, Klebsiella pneumonia, Pseudomonas aeruginosa) but also
more activity to the atypical bacteria (Chlamydia, Mycoplasma). In this
retrospective study, we evaluated the converting ratio between injection
and oral forms. This drug utilizing evaluation (DUE) study will help to elevate
the reasonable using of levofloxacin in the hospital.
Methods: This study is a retrospective study in a regional hospital. Cases
were collected from April 2014 to June 2014 for all hospitalized patients us-
ing Levofloxacin. The reasonableness assessment of Levofloxacin prescribing
included indications, doses, bacterial culture or consulted with Infectious
Diseases physician. The recommendation doses for renal dysfunction fol-
lowed by SANFORD GUIDE. Patient’s creatinine clearance (Clcr) was
monitoring for adjusting the therapeutic dose accordingly. Descriptive sta-
tistical analysis was performed in the study.
Results: Total 158 cases were recruited in the study. The bacterial culture was
performed in 157 cases (99.4%). Depending on bacterial culture results, consid-
ering as reasonable using levofloxacinwas 86 cases (54.4% ), and empirical ther-
apy counted as 61 (38.6% ), which were also consulted with Infectious Diseases
physician prior to administration. In addition, 158 cases (100%) were monitored
Clcr, 143 cases (90.5%) had performed dose adjustments in accordance with
appropriate therapeutic doses by renal function. Moreover, 23 cases used injec-
tion form over 7 days during hospitalization period, 3 cases (13.0%) switched to
oral form during hospitalization period, 12 cases (52.2%) did not switch during
hospitalization period, 8 cases of them (8/23, 34.8%) did not switch during hos-
pitalization period but took home with oral levofloxacin.
Conclusion: This study showed that the reasonableness of the use of Levo-
floxacin was counted as 86 cases (54.4%). The ratio of injection dosage
form converted to oral form was not ideally. The results will provide physi-
cians to use the build-in computerized physician order entry system remind-
ing to improve the efficacy of levofloxacin.
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EVALUATION OF PIPERACILLIN/TAZOBACTAM UTILIZATION
APPROPRIATENESS
Hsin-Chun Lai 1, Tien-Yuan Wu 2, Yung-Ta Lin 2, Chi-Hua Chen 3.
1Pharmaceutic Division, Department of Pharmacy, Taichung Tzu Chi
Hospital, Buddhist Tzu Chi Medical Fundation; 2Clinical Pharmacy Division,
Department of Pharmacy, Taichung Tzu Chi Hospital, Buddhist Tzu Chi
Medical Fundation; 3Department of Pharmacy, Taichung Tzu Chi Hospital,
Buddhist Tzu Chi Medical Fundation, Taichung, Taiwan
Purposes: The aim of this study was to evaluate the appropriateness of
piperacillin/ tazobactam (Tapimycin; YUNGSHIN, Taichung, TW) usage in
a regional hospital, retrospectively.
Methods: This retrospective study was designed to recurit all patients
admitted to the regional hospital with prescribing Tapimycin from
October, 2013 to December, 2013. The electronic medical records were
reviewed and studied, respectively. We collected patient’s data including
demographics, empirical indication, infusion time, dose and dosing inter-
val, culture and susceptible results, concomitant antibiotics, and de-esca-
lation of the antimicrobial regimen. The endpoint of overall
appropriateness was evaluated and dose adjustment following renal func-
tion monitoring by creatinine clearance (Clcr) calculated by Cockcroft-
Gault Equation.
Results: During this period, 181 cases, 112 female cases and 69 male cases
were obtained from 159 patients. The average age of the cases was 67.4 
16.59. The average administration day was 10.01  4.25. The main indica-
tion for initiation administration was pneumonia (109/181; 60%). There
were 41 (41/360, 11.39%) isolations as Pseudomonas aeruginosa; 35 (35/
360, 9.72%) were Klebsiella pneumoniae; 21 (21/360, 5.83%) were Escher-
ichia coli. Thirty-seven (20.44%) cases infusion time were longer than 60
min. There were 111 cases (61.33%) with normal renal function. Renal
dysfunction with dosage adjustment was counted as 51 cases (28.18%).
However, there were 13 cases (7.18%) with renal dysfunction without
dose or dosing interval adjustment. At the endpoint of evaluation, 72 cases
(40%) where antibiotics were changed to narrow-spectrum antimicrobials
or oral antibiotics were considered as de-escalation. The overall rate of
appropriateness of Tapimycin therapy was 138/181 (76%).
Conclusion: Our results present the tendency toward the appropriate rate of
Tapimycin utilization at our institution was only 76%, especially, when the
selection of treatment based on initial empirical therapy was inappropriate.
Without dosing adjustment was given the concerns about the increasing
occurrence of antibiotic adverse events. Further studies may be performed
to establish guidance ideally in the future.
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ASSOCIATION BETWEEN ANTIMICROBIAL TREATMENT WITH
FLUOROQUINOLONES VERSUS b-LACTAMASE INHIBITOR AND RISK OF
PNEUMONIA-RELATED HOSPITALIZATION AMONG PATIENTS WITH
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Kuan-Yin Lin 1, Chi-Chuan Wang 2, Wang-Huei Sheng 3, Shan-
Chwen Chang 3. 1Department of Emergency Medicine, National Taiwan
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